Business Wire·May 19, 2026, 7:00 AM ET

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

BLCO TSX:BLCO

Bausch + Lomb announced the U.S. launch of PreserVision AREDS3 eye vitamins to reduce the risk of moderate-to-advanced age-related macular degeneration (AMD) progression.
The formula combines clinically proven AREDS2 nutrients recommended by the National Eye Institute with a unique B-vitamin complex containing thiamin, riboflavin, niacin, pantothenic acid, vitamin B6, biotin, folate, and vitamin B12.
PreserVision AREDS3 is designed to support a broader range of people, including those in earlier stages of AMD, by enabling nutritional support to be initiated sooner.
The product features a triple-action formula intended to protect, nourish, and boost macular health through free radical neutralization, promotion of healthy cellular function, and two times better absorption of key nutrients.
Development of the formula was guided by scientific evidence from a narrative review in Ophthalmology and Therapy and over two decades of research involving nearly 30,000 individuals.
A long-term clinical trial evaluating the formulation is currently in planning stages.
PreserVision AREDS3 is now available at most nationwide retailers, including Amazon, Target, Walgreens, and Walmart.
PreserVision remains the No. 1 eye doctor-recommended AREDS brand with a portfolio built on decades of scientific collaboration.
AMD affects approximately 28 million older Americans and is the leading cause of vision loss in this demographic.
The product statement has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease.